
Significant insider selling has been a strong bearish indicator since 2021, often preceding stock underperformance for the next 1 to 12 months. A current example is Hims & Hers Health (HIMS), which could face pressure due to a large CEO sale combined with slowing business growth. Conversely, insider buying is most effective when it aligns with a positive trend for the entire sector. For instance, insider buying at Tilray Brands (TLRY) preceded a major rally, supported by a bullish outlook for the cannabis industry. This same strategy proved successful for Kratos Defense & Security Solutions (KTOS), where CEO buying combined with a favorable view of the defense industry led to strong gains.
The core investment strategy discussed is based on analyzing the trading activity of company insiders (like CEOs and executives).
Insider Selling is a Stronger Signal: The speaker argues that, since at least 2021, insider selling has been a more reliable indicator than insider buying.
Insider Buying is a Weaker Signal: When insiders buy, the stock does not consistently outperform the market.